Nathan Bair joined Clark+Elbing in 2019. His work involves the drafting and prosecution of patent applications, primarily in the field of chemistry.
As an undergraduate Nathan began research focused on the construction of a novel organophotovoltaic cell design employing a hybrid inorganic-organic-nanoparticle (CdSe) core. As a M.S. candidate he went on to test excited electron lifetimes in the CdSe nanoparticles using time-correlated single photon counting.
Nathan transitioned to the interface of organic synthesis and chemical biology during his Ph.D. and postdoctoral research. He contributed to the elucidation of the biosynthesis of the hapalindole core, the enzymatic synthesis of non-natural hapalindole analogues, and improved on previous methods for synthesizing isonitrile-containing hapalindole molecules. He then helped establish a new project focused on the synthesis and testing of small molecules as PKC-δ inhibitors.
Nathan’s varied experience and interests, from photovoltaic cells to small molecule drug targets and enzymatic assays, led him to pursue a career where he can be involved in the strategic and legal development of a range of scientific advancements.
Select Awards & Honors:
- Rodney Bush Fellowship in Organic Chemistry 2011
- Kenneth W. Brighton Scholarship 2007 and 2008
- Undergraduate Research Award 2006, 2007, and 2008